Will FDA approve any type of personalized cancer mRNA vaccines before 2028?
Plus
12
Ṁ10392027
84%
chance
1D
1W
1M
ALL
Resolves YES if the FDA grants full approval for the commercial sale of any type of personalized cancer mRNA vaccines in the United States before January 1, 2028. This does not include emergency use authorization or other forms of limited authorization. Resolves NO otherwise.
This question is managed and resolved by Manifold.
Get
1,000and
3.00
1,0003.00Sort by:
"Pancreatic Cancer Vaccine Shows Promise in Small Trial: Using mRNA tailored to each patient’s tumor, the vaccine may have staved off the return of one of the deadliest forms of cancer in half of those who received it."
https://www.nytimes.com/2023/05/10/health/pancreatic-cancer-vaccine-mrna.html
Related questions
Related questions
Will FDA approve any mRNA vaccine against any type of breast cancer before 2028?
31% chance
Will FDA approve any mRNA vaccine against melanoma before 2028?
49% chance
Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
43% chance
Will FDA approve any mRNA vaccine against squamous cell carcinoma before 2028?
35% chance
Will FDA approve any mRNA vaccine against myeloid leukemia before 2028?
34% chance
Will FDA approve any mRNA vaccine against colorectal adenocarcinoma before 2028?
30% chance
Will FDA approve any mRNA vaccine against esophageal adenocarcinoma before 2028?
33% chance
Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028?
41% chance
Will FDA approve any mRNA vaccine against lymphoblastic leukemia before 2028?
34% chance
Will FDA approve any mRNA vaccine against pancreatic adenocarcinoma before 2028?
19% chance